In vivo Application of Chitosan to Facilitate Intestinal Acyclovir Absorption in Rats

• Published in: Journal of pharmaceutical sciences Vol. 101; no. 7; pp. 2449 - 2456
• Main Authors: Masuda, Ayumi, Goto, Yuko, Kurosaki, Yuji, Aiba, Tetsuya
• Format: Journal Article
• Language: English
• Published: Hoboken Elsevier Inc 01.07.2012; Wiley Subscription Services, Inc., A Wiley Company; Wiley; American Pharmaceutical Association; Elsevier Limited
• Subjects: absorption enhancer; acyclovir; Acyclovir - administration & dosage; Acyclovir - pharmacokinetics; Animals; Antiviral Agents - administration & dosage; Antiviral Agents - pharmacokinetics; bioavailability; Biological and medical sciences; chitosan; Chitosan - chemistry; Chitosan - metabolism; chitosanase; General pharmacology; Glycoside Hydrolases - metabolism; Intestinal Absorption; Jejunum - metabolism; Male; Medical sciences; Pharmaceutical technology. Pharmaceutical industry; Pharmaceutical Vehicles - chemistry; Pharmacology. Drug treatments; polycation; Rats; Rats, Wistar; Streptomyces - enzymology; Viscosity; chitosan; viscosity; bioavailability; polycation; acyclovir; intestinal absorption; absorption enhancer; chitosanase; Viscosity; Acyclic nucleoside; Purine nucleoside; Rat; Absorption; Aciclovir; Nucleoside analog; Antiviral; DNA polymerase inhibitor; Pharmaceutical technology; Enzyme; Rodentia; Gut; Polymer; Bioavailability; Glycosylases; In vivo; Vertebrata; Mammalia; Polycation; Glycosidases; Animal; Chitosanase; Hydrolases; Oside polymer; Absorption enhancer; Chitosan; Pharmacokinetics
• ISSN: 0022-3549; 1520-6017
• DOI: 10.1002/jps.23170

The effect of chitosan on the intestinal absorption of acyclovir (ACV) was evaluated in rats, and factors influencing its facilitative effect on the ACV absorption were examined. When ACV solution containing 1% chitosan with an average molecular weight of 150kDa was administered into the upper jejunum, a significant increase in the plasma ACV concentration was observed, with the peak ACV concentration being eight times greater than that observed with the chitosan-free solution. The chitosan-free ACV solution, whose viscosity was adjusted to remain unchanged with polyethylene glycol, did not cause an increase in the plasma concentration, and neither did the chitosan-free solutions substitutionally containing low molecular cationic compounds, triethanolamine and kanamycin. When chitosan was digested with chitosanase to shorten its polycationic polysaccharide structure, chitosan subjected to 150-min digestion retained its facilitative effect on ACV absorption, but that subjected to 420-min digestion no longer caused facilitation, in which its average molecular weight was reduced to around 10kDa. It is therefore indicated that intestinal ACV absorption can be facilitated with chitosan, and that it is necessary for chitosan to have a certain length of polycationic polysaccharide structure to exert such facilitation. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association.